TON - October 2013 Vol 6 No 9
Further analyses of Study 301, which compared eribulin to capecitabine in the treatment of advanced breast cancer, showed greater improvements in quality of life (QOL) with eribulin, and overall survival (OS) benefits in subsets of patients.
I Get By With a Little Help From My Friends: The Role of the Support Group in Breast Cancer Survivorship
“Wow, those meetings must be sober events.” I’ve gotten this and other similar comments regularly over the past 6½ years since I received my diagnosis of stage III breast cancer in 2007. Fortunately for me and many other women, the assumption couldn’t be less accurate.
October is National Breast Cancer Awareness Month. The September 30, 2013, presidential proclamation acknowledging this points out that “This disease touches every corner of the United States—in 2013 alone, more than 230,000 women and over 2,000 men will be diagnosed with breast cancer, and tens of thousands will die from it.”
Would I have a chance to be accepted, as I did not technically qualify as a “breast cancer activist,” was the thought that raced through my mind as I viewed the following description on the National Breast Cancer Coalition (NBCC) website?
TON - October 2013 Vol 6 No 9 published on October 30, 2013
The word survivor has come to be widely identified and associated with words such as courage, heroine, brave, and fighter. Thus, it might surprise many that this socially endeared title is often debated in the breast cancer community.
The University of Arizona Cancer Center is a National Cancer In- stitute (NCI)-designated comprehensive cancer center, providing excellence in patient care as well as a focus on the development and delivery of therapies to reduce cancer-associated morbidity and mortality.
Results 1 - 8 of 8